Major bleeding risks of different low-molecular-weight heparin agents: a cohort study in 12 934 patients treated for acute venous thrombosis

Author(s):
Rein, N. van; Biedermann, J.S.; Meer, F.J.M. van der (0000-0002-0221-9618); Cannegieter, S.C. (0000-0003-4707-2303); Wiersma, N.; Vermaas, H.W.; Reitsma, P.H. (0000-0003-2207-1830); Kruip, M.J.H.A.; Lijfering, W.M.
Published
2017
Publication type
Article / Letter to editor
adverse effectshemorrhageheparinhumanslow-molecular-weightvenous thrombosis
Date issued
2017-07-31
Language
English
Is part of
Journal of Thrombosis and Haemostasis (2017), Vol. 15, no. 7, p. 1386-1391
hdl
1887/115532
doi
10.1111/jth.13715